Souvenir II.
Completed
- Conditions
- Alzheimer’s Disease
- Registration Number
- NL-OMON23021
- Lead Sponsor
- Danone Research, Centre For Specialised Nutrition
- Brief Summary
Scheltens et al. J Alzheimers Dis. 2012 31(1):225-36.<br> De Waal et al. PLoS ONE. 2014 9(1): e86558.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 226
Inclusion Criteria
1. Diagnosis of probable AD according to the NINCDS-ADRDA criteria;
2. MRI or CT scan within two years before baseline showing no evidence of any other potential cause of dementia other than AD;
Exclusion Criteria
1. Diagnosis of significant neurological disease other than AD;
2. Use within 3 months prior to baseline, or expected need during the study of approved anti-AD medication;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Memory performance (NTB) during 24 weeks of intervention.
- Secondary Outcome Measures
Name Time Method Cognition (NTB), DAD, EEG (exploratory MEG in a subset of subjects), Nutritional blood parameters, tolerance and safety during 24 weeks of intervention.<br>Exploratory MEG in a subset of subjects.